Page 26 - NAMAH-Apr-2018
P. 26

Namah                                    Vol. 26, Issue 1, 24th April 2018





                                  Additionally, all
                                  biomarkers decreased in
                                  the treatment group and
                                  no improvement in the
                                  placebo (30).
         Irritable     8 weeks    Prevalence of IBS      One of 72 mg. or two tablets
         bowel                    decreased by 53% in    of 72 mg. each, standardised
         syndrome                 the one-tablet group   turmeric extract taken daily for
                                  and 60% in the two-    8 weeks
                                  tablet group. Additional
                                  abdominal pain and
                                  discomfort decreased
                                  (31).
         Gastric ulcer Phase II   Ulcers completely      600 mg with powdered turmeric
                                  healed in 48% after 4   5 t/d
                                  weeks and 76% after 12   Or placebo.
                                  weeks. (32).

        Summary of clinical findings

        The underlying actions and clinical effects of turmeric are: 1)anti-inflammatory, 2)anti-
        microbial, 3) anti-oxidant, and 4) wound-healing properties. The clinical trial data suggest that
        turmeric either alone or in combination with conventional modalities reduces the morbidity or
        mortality from several disease states. Use of turmeric along with the conventional modalities
        has indicated better health outcomes after turmeric use, reducing the adverse events profile.

        Using turmeric as a medicinal agent may change the course of several chronic diseases
        such as arthritis, allergic rhinitis, asthma, cancer (breast, pancreatic, prostate, colorectal,
        lung, multiplemyeloma), cardiovascular disease, diabetes, digestive disorders such
        as irritable bowel syndrome and gastric ulcer to name a few disease states. While the
        mechanism of action is not entirely clear as to how turmeric works, clinical trial data
        for cancer show its influence in inhibiting networks of cancer cell growth for example.
        Curcumin is a natural polyphenol molecule derived from the Curcuma longa plant which
        exhibits anticancer, chemo-preventive, chemo- and radio-sensitization properties.
        Curcumin increases the sensitivity of chemotherapeutic drugs and protects from toxicity
        of cancer therapy.

        Dosage range

        Doses of 500-8,000 mg. of turmeric per day have been used in human studies. Standardised
        extracts are typically used in lower amounts, in the 250-2,000 mg. range (33).


        26
   21   22   23   24   25   26   27   28   29   30   31